EGFR Amplification and Sensitizing Mutations Correlates with Survival from Erlotinib in Lung Adenocarcinoma Patients (MutP-CLICAPP)

被引：0

作者：

Cardona, A. ^{[1
]}

Ruiz-Patino, A. ^{[1
]}

Castro, C. ^{[1
]}

Rojas, L. ^{[2
]}

Arrieta, O. ^{[3
,4
]}

Zatarain-Barron, Z. ^{[5
,6
]}

Carranza, H. ^{[1
]}

Vargas, C. ^{[1
]}

Otero, J. ^{[1
]}

Corrales, L. ^{[7
]}

Martin, C. ^{[8
]}

Rosell, R. ^{[9
]}

机构：

[1] Fdn Clin & Appl Canc Res Ficmac, Clin & Translat Oncol Grp, Bogota, Colombia

[2] Clin Univ Colombia, Med Oncol, Bogota, Colombia

[3] Natl Canc Inst, Unidad Func Oncol Torac, Mexico City, DF, Mexico

[4] Natl Canc Inst, Lab Med Personalizada, Mexico City, DF, Mexico

[5] Inst Nacl Cancerol, Thorac Oncol Unit, Mexico City, DF, Mexico

[6] Inst Nacl Cancerol, Lab Personalized Med, Mexico City, DF, Mexico

[7] Hosp San Jose, Clin Oncol, San Jose, Costa Rica

[8] Inst Alexander Fleming, Dept Clin Oncol, Buenos Aires, DF, Argentina

[9] Germans Trias & Pujol Hlth Sci Inst & Hosp, Canc Biol & Precis Med Program, Catalan Inst Oncol, Barcelona, Spain

来源：

JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期

关键词：

EGFR mutations; EGFR amplification; Adenocarcinoma;

D O I：

10.1016/j.jtho.2018.08.1406

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P2.13-11

引用

页码：S802 / S802

页数：1

共 50 条

[31] EGFR and KRAS mutations are molecular predictors of survival in resected lung adenocarcinoma
Marks, Jenifer L.
Broderick, Stephen
Seshan, Venkatraman E.
Zakowski, Maureen F.
Li, Allan
Wilson, Richard
Kris, Mark G.
Ladanyi, Mark
Rusch, Valerie W.
Pao, William
JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S480 - S481
[32] Detection of EGFR TKI sensitizing mutations from metastatic pleural fluid secondary to lung adenocarcinoma: a perspective from Southern India
Dhar, C.
Sharma, M.
Nawaz, M. S.
D'Souza, G.
Srivastava, S.
MOLECULAR BIOLOGY OF THE CELL, 2018, 29 (26) : 215 - 216
[33] Case Series of Egfr Double Mutations in Patients with Lung Adenocarcinoma
Vilches, Natalia
Flores Gutierrez, Juan Pablo
Barboza, Oralia
Lopez, Karina E.
Garza, Raquel
MODERN PATHOLOGY, 2018, 31 : 754 - 754
[34] Case Series of Egfr Double Mutations in Patients with Lung Adenocarcinoma
Vilches, Natalia
Flores Gutierrez, Juan Pablo
Barboza, Oralia
Lopez, Karina E.
Garza, Raquel
LABORATORY INVESTIGATION, 2018, 98 : 754 - 754
[35] FREQUENCY AND SPECTRUM OF EGFR MUTATIONS IN MOROCCAN LUNG ADENOCARCINOMA PATIENTS
Elghissassi, I.
Inrhaoun, H.
Boukir, A.
Bensouda, Y.
Mrabti, H.
Errihani, H.
ANNALS OF ONCOLOGY, 2012, 23 : 432 - 432
[36] Mapping EGFR1 Mutations in Patients With Lung Adenocarcinoma
Vlastos, Fotis
Zinszner, Julie
Hussenet, Thomas
du Manoir, Stanislas
Vordonis, Leonidas
Nikolakopoulou, Sofia
Hardavella, Georgia
Lacomme, Stefanie
Vignaud, Jean Michel
Martinet, Nadine
DIAGNOSTIC MOLECULAR PATHOLOGY, 2010, 19 (04) : 209 - 217
[37] Long-term survival of NSCLC patients with EGFR mutations treated with EGFR TKIs gefitinib or erlotinib
Janne, R
Sequist, L
Lindeman, N
Bell, D
Huberman, M
Meyerson, M
Haber, D
Lynch, T
Johnson, B
LUNG CANCER, 2005, 49 : S109 - S109
[38] Impact on Disease-Free Survival of Adjuvant Erlotinib or Gefitinib in Patients with Resected Lung Adenocarcinomas that Harbor EGFR Mutations
Janjigian, Yelena Y.
Park, Bernard J.
Zakowski, Maureen F.
Ladanyi, Marc
Pao, William
D'Angelo, Sandra P.
Kris, Mark G.
Shen, Ronglai
Zheng, Junting
Azzoli, Christopher G.
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (03) : 569 - 575
[39] Impact of EGFR and KRAS mutations on survival in 1,000 patients with resected lung adenocarcinoma.
D'Angelo, S. P.
Janjigian, Y. Y.
Kris, M. G.
Pao, W.
Riely, G. J.
Marks, J.
Sima, C.
Dycoco, J.
Park, B. J.
Azzoli, C. G.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[40] Molecular Characterization of EGFR Somatic Mutations in Lung Adenocarcinoma Tumors from Chilean Patients
Sepulveda-Hermosilla, G.
Blanco, A.
Lizana, R.
Ramos, L.
Freire, M.
Spencer, M.
Chernilo, S.
Aren, O.
Perez, P.
Armisen, R.
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (09) : S157 - S157

← 1 2 3 4 5 →